NICU admission:
Nine studies examined NICU admission with or without pravastatin
treatment. Pravastatin treatment was associated with a significantly
decreased risk for NICU admission compared to women not treated with
statins (OR=0.42, 95%CI: 0.23-0.75, p=0.004, I2=25%)
(Figure 3).